U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 20 - 26, 2018
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 20 - 26, 2018

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name: Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date: 05/21/2018
Location: Silver Spring, MD
Subject: Collaborating on Countering the Opioid Epidemic
FDA Participant/Group: Silvis, Lauren R; Sipes, Grail W; Nguyen, Martha C; Fine, Anna; Franklin, Joseph B; Robb, Melissa A; Moran, Kristine M; Quinn, Kathleen K;
Non FDA Participant/Group: Elizabeth Finkelman, Guru Madhavan, Sharyl Nass, Victor Dzau(The National Academy of Medicine);

Event Date: 05/22/2018
Location: Washington, DC
Subject: Alliance for Regenerative Medicine's Annual Board Meeting: FDA's Regulatory Framework for Regenerative Medicine Products
FDA Participant/Group: Devlin, Nina P;
Non FDA Participant/Group: Industry, congressional staff, patient advocacy groups, government and other invited individuals

Event Date: 05/22/2018
Location: Washington, DC
Subject: The Wall Street Journal Health Forum: How Innovation Is Reshaping the Business of Health
FDA Participant/Group: Devlin, Nina P;
Non FDA Participant/Group: Industry, government, media, academia and other invited participants

Event Date: 05/23/2018
Location: Washington, DC
Subject: State of Care: Patient Access and Affordability
FDA Participant/Group: Quinn, Kathleen K;
Non FDA Participant/Group: Media, government, patient advocacy organizations, congressional staff and other invited individuals

Official Name: Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy

Event Date: 05/20/2018
Location: Geneva, Switzerland
Subject: 71st World Health Assembly: World Health Organization
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members from the World Health Organization Member States

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton , Acting Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/23/2018
Location: Baltimore, MD
Subject: International Society for Pharmacoeconomics and Outcomes Research: The Transformational Role of Digital Health
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 05/24/2018
Location: Silver Spring, MD
Subject: Medical Device Innovation Consortium (MDIC): Clinical Science & Medical Officer Quarterly Meeting
FDA Participant/Group: Schwartz, Suzanne B; Gross, Thomas G; O callaghan, Kathryn; Faris, Owen P; Fink, Rochelle C;
Non FDA Participant/Group: Rick Kuntz(Medtronic ); Mark Carlson(Abbott); Christine Lim, Jijo James(Johnson & Johnson Services Incorporated); Pamela Goldberg, Stephanie Christopher, Carolyn Hiller, Dan Schwartz(The Medical Device Innovation Consortium ); Wes Cetnarowski, Rebecca Stolarick(B. Braun Medical Incorporated); Alan Wright(F. Hoffmann-La Roche Limited); Sumant Ramachandra(Baxter); Brian Duncan(LivaNova PLC ); Liz Galle(CVRx ); Marc Lanser(Stryker Corporation ); Pieter Kappetein(Medtronic); Seth Bilazarian(Abiomed); Dottie Clower(Cohera Medical Incorporated); Jennifer Kerr(Cook Research Incorporated );

Official Name: Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Rebecca K. Wood, J.D., Chief Counsel

No Significant Event

Back to Top